Oleg V Dolotov, Ekaterina A Karpenko, Lyudmila S Inozemtseva, Tamara S Seredenina, Natalia G Levitskaya, Joanna Rozyczka, Elena V Dubynina, Ekaterina V Novosadova, Lyudmila A Andreeva, Lyudmila Yu Alfeeva, Andrey A Kamensky, Igor A Grivennikov, Nikolay F Myasoedov, Jürgen Engele
Index: Brain Res. 1117(1) , 54-60, (2006)
Full Text: HTML
The heptapeptide Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is an analog of the adrenocorticotropin fragment (4-10) which after intranasal application has profound effects on learning and exerts marked neuroprotective activities. Here, we found that a single application of Semax (50 microg/kg body weight) results in a maximal 1.4-fold increase of BDNF protein levels accompanying with 1.6-fold increase of trkB tyrosine phosporylation levels, and a 3-fold and a 2-fold increase of exon III BDNF and trkB mRNA levels, respectively, in the rat hippocampus. Semax-treated animals showed a distinct increase in the number of conditioned avoidance reactions. We suggest that Semax affects cognitive brain functions by modulating the expression and the activation of the hippocampal BDNF/trkB system.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
ACTH (4-10)
CAS:4037-01-8 |
C44H59N13O10S |
Ligand-dependent activation of the melanocortin 5 receptor: ...
2002-01-18 [Biochem. Biophys. Res. Commun. 290 , 844-850, (2002)] |
Sniffing neuropeptides: a transnasal approach to the human b...
2002-06-01 [Nat. Neurosci. 5(6) , 514-6, (2002)] |
The melanocortin melanocyte-stimulating hormone/adrenocortic...
2001-03-01 [J. Clin. Endocrinol. Metab. 86(3) , 1144-8, (2001)] |
Advanced glycation end products modulate the maturation and ...
2004-06-01 [Diabetes 53(6) , 1452-8, (2004)] |
Intranasal application of the melanocortin 4 receptor agonis...
2012-05-01 [Int. J. Obes. 36(5) , 703-8, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved